Correlation Between Regeneron Pharmaceuticals and Valneva SE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Valneva SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Valneva SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Valneva SE ADR, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Valneva SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Valneva SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Valneva SE.

Diversification Opportunities for Regeneron Pharmaceuticals and Valneva SE

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Regeneron and Valneva is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Valneva SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valneva SE ADR and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Valneva SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valneva SE ADR has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Valneva SE go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Valneva SE

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Valneva SE. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 1.64 times less risky than Valneva SE. The stock trades about -0.14 of its potential returns per unit of risk. The Valneva SE ADR is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest  472.00  in Valneva SE ADR on November 3, 2024 and sell it today you would earn a total of  106.00  from holding Valneva SE ADR or generate 22.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Regeneron Pharmaceuticals  vs.  Valneva SE ADR

 Performance 
       Timeline  
Regeneron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Valneva SE ADR 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Valneva SE ADR are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy essential indicators, Valneva SE is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Regeneron Pharmaceuticals and Valneva SE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regeneron Pharmaceuticals and Valneva SE

The main advantage of trading using opposite Regeneron Pharmaceuticals and Valneva SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Valneva SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will offset losses from the drop in Valneva SE's long position.
The idea behind Regeneron Pharmaceuticals and Valneva SE ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets